Quinidine Gluconate Tablet, Extended Release
Product Images NDC 71930-016

2 FDA label images from Eywa Pharma Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Quinidine Gluconate (NDC 71930-016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eywa Pharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Img-quin (Img Quin)

Img-quin (Img Quin)
Label for Quinidine Gluconate Extended-Release Tablets, USP 324 mg, oral tablets by Eywa Pharma Inc. The label includes the NDC 71930-016-12, prescription only, and states the package contains 100 tablets. Storage instructions specify 20° to 25°C, with manufacturer WES Pharma Inc and distributor Eywa Pharma Inc information provided.*
FDA Label Image

Struct (Struct Quin)

Struct (Struct Quin)
Chemical structure diagram of Quinidine gluconate showing its molecular composition and arrangement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.